Tumor safety and side effects of photobiomodulation therapy used for prevention and management of cancer treatment toxicities. A systematic review.

Humans Low-Level Light Therapy Lymphedema / etiology Neoplasms / therapy Randomized Controlled Trials as Topic Stomatitis / etiology Treatment Outcome
Cancer Cancer treatment toxicities Laser Mucositis Photobiomodulation Safety Side effect Systematic review

Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
06 2019
Historique:
received: 16 01 2019
revised: 03 04 2019
accepted: 05 04 2019
entrez: 22 5 2019
pubmed: 22 5 2019
medline: 6 5 2020
Statut: ppublish

Résumé

Photobiomodulation therapy (PBMT), also known as low-level laser therapy (LLLT), has been increasingly used for the treatment of toxicities related to cancer treatment. One of the challenges for the universal acceptance of PBMT use in cancer patients is whether or not there is a potential for the light to stimulate the growth of residual malignant cells that evaded oncologic treatment, increasing the risk for tumor recurrences and development of a second primary tumor. Current science suggests promising effects of PBMT in the prevention and treatment of breast cancer-related lymphedema and oral mucositis, among other cancer treatment toxicities. Nevertheless, this seems to be the first systematic review to analyze the safety of the use of PBMT for the management of cancer-related toxicities. Scopus, MEDLINE/PubMed, and Embase were searched electronically. A total of 27 articles met the search criteria. Selected studies included the use of PBMT for prevention and treatment of oral mucositis, lymphedema, radiodermatitis, and peripheral neuropathy. Most studies showed that no side effects were observed with the use of PBMT. The results of this systematic review, based on current literature, suggest that the use of PBMT in the prevention and management of cancer treatment toxicities does not lead to the development of tumor safety issues.

Identifiants

DOI: 10.1016/j.oraloncology.2019.04.004 PMID: 31109692
pubmed: 31109692
pii: S1368-8375(19)30105-8
doi: 10.1016/j.oraloncology.2019.04.004
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-28

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Mariana de Pauli Paglioni (M)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil.

Anna Luíza Damaceno Araújo (ALD)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil.

Lady Paola Aristizábal Arboleda (LPA)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil.

Natalia Rangel Palmier (NR)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil.

Jéssica Montenegro Fonsêca (JM)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil.

Wagner Gomes-Silva (W)

Dental Oncology Service, São Paulo State Cancer Institute (ICESP-FMUSP), Brazil; Medical School, Nove de Julho University, São Paulo, Brazil.

Cristhian Camilo Madrid-Troconis (CC)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil; Dentistry Program, Corporación Universitaria Rafael Nuñez, Cartagena, Colombia.

Felipe Martins Silveira (FM)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil.

Manoela Domingues Martins (MD)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil; Department of Oral Pathology, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.

Karina Morais Faria (KM)

Dental Oncology Service, São Paulo State Cancer Institute (ICESP-FMUSP), Brazil.

Ana Carolina Prado Ribeiro (ACP)

Dental Oncology Service, São Paulo State Cancer Institute (ICESP-FMUSP), Brazil.

Thaís Bianca Brandão (TB)

Dental Oncology Service, São Paulo State Cancer Institute (ICESP-FMUSP), Brazil.

Marcio Ajudarte Lopes (MA)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil.

Adriana Franco Paes Leme (AFP)

Brazilian Biosciences National Laboratory, LNBio, CNPEM, Campinas, São Paulo, Brazil.

César Augusto Migliorati (CA)

College of Dentistry, University of Florida, Gainesville, FL, USA.

Alan Roger Santos-Silva (AR)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil. Electronic address: alan@unicamp.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Tumor safety and side effects of...
questionsmedicales.fr › Thérapeutique › Photothérapie › Photothérapie de faible intensité › Tumor safety and side effects of...
questionsmedicales.fr › Hémopathies et maladies lymphatiques › Maladies lymphatiques › Lymphoedème › Tumor safety and side effects of...
questionsmedicales.fr › Tumeurs › Tumor safety and side effects of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études cliniques comme sujet › Essais cliniques comme sujet › Essais cliniques contrôlés comme sujet › Essais contrôlés randomisés comme sujet › Tumor safety and side effects of...
questionsmedicales.fr › Maladies du système stomatognathique › Maladies de la bouche › Stomatite › Tumor safety and side effects of...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Tumor safety and side effects of...